Home › Non-Small Cell Lung Cancer › Alabama › Huntsville
Non-Small Cell Lung Cancer clinical trials in Huntsville, AL
3 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Huntsville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RecruitingPhase 2
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RecruitingPhase 3
- Clearview Cancer Institute, Huntsville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- Clearview Cancer Institute, Huntsville
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Huntsville
- Cardiovascular Disease8 studies
- Obesity7 studies
- Coronary Artery Disease6 studies
- Heart Failure6 studies
- Major Depressive Disorder6 studies
- Type 2 Diabetes6 studies
- Depression6 studies
- Atherosclerosis5 studies
- Overweight5 studies
- Aortic Valve Stenosis4 studies
- Chronic Kidney Disease4 studies
- Heart Attack3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.